Free Trial

Pebblebrook Hotel Trust (PEB) Financials

Pebblebrook Hotel Trust logo
$9.73 -0.30 (-2.99%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$9.70 -0.03 (-0.26%)
As of 08/1/2025 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Pebblebrook Hotel Trust

Annual Income Statements for Pebblebrook Hotel Trust

This table shows Pebblebrook Hotel Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
48 69 47 84 -4.07 83 -424 -235 -124 -113 -47
Consolidated Net Income / (Loss)
74 95 74 100 13 116 -393 -186 -85 -74 0.02
Net Income / (Loss) Continuing Operations
74 95 74 100 13 116 -393 -186 -85 -74 0.02
Total Pre-Tax Income
77 98 74 100 15 121 -396 -186 -85 -74 -26
Total Revenue
574 735 775 732 775 -108 -104 -97 1,292 -116 -112
Net Interest Income / (Expense)
-25 -36 -42 -37 -54 -108 -104 -97 -100 -116 -112
Total Interest Income
2.53 2.51 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
27 39 44 37 54 108 104 97 100 116 112
Long-Term Debt Interest Expense
27 39 44 37 54 108 104 97 100 116 112
Total Non-Interest Income
599 771 816 769 829 0.00 0.00 0.00 1,392 0.00 0.00
Total Non-Interest Expense
508 643 636 634 762 -229 293 90 1,377 -38 -84
Net Occupancy & Equipment Expense
269 339 - - 2.15 971 262 497 - 941 961
Property & Liability Insurance Claims
37 47 50 49 54 125 114 112 126 125 126
Other Operating Expenses
133 161 471 483 522 43 50 40 928 24 4.42
Depreciation Expense
68 96 102 102 108 235 225 224 240 241 230
Impairment Charge
0.00 0.00 12 - 0.00 0.00 75 15 90 82 48
Other Special Charges
- - - - - -1,612 -443 -798 -6.19 -1,450 -1,453
Nonoperating Income / (Expense), net
10 6.21 -65 2.36 2.08 0.03 0.52 0.11 0.56 4.23 2.79
Income Tax Expense
3.25 2.59 -0.13 0.18 1.74 5.17 -3.70 0.06 0.28 0.66 -26
Preferred Stock Dividends Declared
25 26 27 16 17 33 33 50 37 35 43
Net Income / (Loss) Attributable to Noncontrolling Interest
0.68 0.33 0.26 0.37 -0.01 0.28 -0.86 -1.51 2.19 3.74 4.26
Basic Earnings per Share
$0.72 $0.95 $0.65 $1.20 ($0.06) $0.63 ($3.25) ($1.80) ($0.95) ($0.93) ($0.39)
Weighted Average Basic Shares Outstanding
65.65M 71.72M 71.90M 69.59M 74.29M 130.47M 130.61M 130.80M 130.45M 121.81M 119.77M
Diluted Earnings per Share
$0.71 $0.94 $0.64 $1.19 ($0.06) $0.63 ($3.25) ($1.80) ($0.95) ($0.93) ($0.39)
Weighted Average Diluted Shares Outstanding
66.26M 72.38M 72.37M 69.98M 74.29M 130.72M 130.61M 130.80M 130.45M 121.81M 119.77M
Weighted Average Basic & Diluted Shares Outstanding
66.40M 72.30M 72.20M 69.80M 67.90M 130.96M 131.32M 131.49M 125.98M 120.29M 119.81M
Cash Dividends to Common per Share
- - - - - - - - - - $0.04

Quarterly Income Statements for Pebblebrook Hotel Trust

This table shows Pebblebrook Hotel Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
-44 -34 34 -68 -45 -39 20 33 -61 -44 7.42
Consolidated Net Income / (Loss)
-40 -22 46 -56 -42 -28 32 45 -50 -32 19
Net Income / (Loss) Continuing Operations
-40 -22 46 -56 -42 -28 32 45 -50 -32 19
Total Pre-Tax Income
-41 -22 46 -56 -42 -27 33 20 -51 -35 27
Total Revenue
1,363 -27 -30 -31 -28 -26 -28 -28 -30 -27 -27
Net Interest Income / (Expense)
-29 -27 -30 -31 -28 -26 -28 -28 -30 -27 -27
Total Interest Income
- 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Expense
29 27 30 31 28 26 28 28 30 27 27
Long-Term Debt Interest Expense
29 27 30 31 28 26 28 28 30 27 27
Total Non-Interest Income
1,392 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Non-Interest Expense
1,404 -5.20 -75 26 16 1.38 -61 -47 23 7.24 -52
Net Occupancy & Equipment Expense
- 214 246 250 231 216 248 257 240 227 254
Property & Liability Insurance Claims
28 29 30 33 33 32 25 35 34 33 34
Other Operating Expenses
894 5.57 -0.44 4.50 15 9.78 6.18 5.72 -17 9.47 9.74
Depreciation Expense
60 58 58 63 61 57 57 58 57 58 58
Other Special Charges
1,072 -312 -408 -396 -334 -314 -397 -405 -338 -320 -408
Nonoperating Income / (Expense), net
0.41 0.18 0.95 1.40 1.69 0.33 0.22 0.79 1.46 -0.97 1.99
Income Tax Expense
-0.74 0.00 0.03 0.82 -0.20 0.05 1.01 -25 -1.47 -3.16 7.81
Preferred Stock Dividends Declared
2.86 11 11 11 2.29 11 11 11 11 11 11
Net Income / (Loss) Attributable to Noncontrolling Interest
0.83 0.88 1.46 0.66 0.74 0.83 1.30 1.49 0.64 0.77 1.23
Basic Earnings per Share
($0.33) ($0.27) $0.27 ($0.57) ($0.36) ($0.32) $0.17 $0.27 ($0.51) ($0.37) $0.06
Weighted Average Basic Shares Outstanding
130.45M 125.49M 121.70M 120.06M 121.81M 120.09M 120.09M 119.64M 119.77M 119.20M 118.17M
Diluted Earnings per Share
($0.32) ($0.27) $0.24 ($0.57) ($0.33) ($0.32) $0.16 $0.24 ($0.47) ($0.37) $0.06
Weighted Average Diluted Shares Outstanding
130.45M 125.49M 151.24M 120.06M 121.81M 120.09M 149.74M 149.35M 119.77M 119.20M 118.38M
Weighted Average Basic & Diluted Shares Outstanding
125.98M 123.11M 120.50M 120.50M 120.29M 120.50M 120.50M 119.69M 119.81M 118.69M 118.57M

Annual Cash Flow Statements for Pebblebrook Hotel Trust

This table details how cash moves in and out of Pebblebrook Hotel Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-2.25 -27 5.03 -8.30 75 -51 79 -44 -40 141 24
Net Cash From Operating Activities
161 221 240 194 136 395 -202 71 279 236 275
Net Cash From Continuing Operating Activities
161 221 240 194 136 395 -202 71 279 236 275
Net Income / (Loss) Continuing Operations
74 95 74 100 13 116 -393 -186 -85 -74 0.02
Consolidated Net Income / (Loss)
74 95 74 100 13 116 -393 -186 -85 -74 0.02
Depreciation Expense
68 96 102 102 108 235 225 224 240 241 230
Amortization Expense
1.65 2.35 4.28 4.92 18 17 17 17 13 12 14
Non-Cash Adjustments to Reconcile Net Income
14 20 49 -3.27 17 14 -14 -33 100 66 13
Changes in Operating Assets and Liabilities, net
4.19 7.10 10 -11 -22 13 -37 50 11 -8.35 18
Net Cash From Investing Activities
-631 -400 298 132 -1,778 300 250 -82 -109 142 -93
Net Cash From Continuing Investing Activities
-631 -400 298 132 -1,778 300 250 -82 -109 142 -93
Purchase of Investment Securities
-580 -305 -0.07 -81 -1,819 -170 -125 -337 -364 -203 -130
Sale and/or Maturity of Investments
1.11 3.02 50 211 40 470 375 256 255 345 37
Net Cash From Financing Activities
468 153 -533 -334 1,718 -746 31 -33 -209 -237 -158
Net Cash From Continuing Financing Activities
468 153 -533 -334 1,718 -746 31 -33 -209 -237 -158
Issuance of Debt
380 815 619 239 2,400 415 1,273 269 1,570 150 400
Repayment of Debt
-139 -546 -918 -348 -557 -938 -1,098 -432 -1,625 -221 -465
Repurchase of Preferred Equity
0.00 0.00 -225 - - 0.00 0.00 -250 -16 -16 0.00
Repurchase of Common Equity
-0.63 -4.09 -2.50 -96 -2.51 -4.01 -1.26 -0.72 -71 -93 -17
Payment of Dividends
-80 -110 -127 -123 -122 -217 -87 -45 -53 -54 -52
Other Financing Activities, Net
-10 -3.51 -5.60 -5.37 -0.47 -0.86 -55 -54 -15 -3.64 -24

Quarterly Cash Flow Statements for Pebblebrook Hotel Trust

This table details how cash moves in and out of Pebblebrook Hotel Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
-158 94 40 5.32 2.03 -129 46 33 73 0.60 49
Net Cash From Operating Activities
24 46 74 82 34 46 84 76 69 50 91
Net Cash From Continuing Operating Activities
24 46 74 82 34 46 84 76 69 50 91
Net Income / (Loss) Continuing Operations
-40 -22 46 -56 -42 -28 32 45 -50 -32 19
Consolidated Net Income / (Loss)
-40 -22 46 -56 -42 -28 32 45 -50 -32 19
Depreciation Expense
60 58 58 63 61 57 57 58 57 58 58
Amortization Expense
3.49 3.01 2.87 3.70 2.55 4.08 2.61 2.61 5.03 2.99 2.90
Non-Cash Adjustments to Reconcile Net Income
8.40 -6.24 -19 76 16 3.99 4.73 -21 25 3.78 11
Changes in Operating Assets and Liabilities, net
-7.53 13 -14 -4.48 -3.30 8.24 -13 -8.72 32 18 -0.24
Net Cash From Investing Activities
-43 105 30 -39 46 -39 -23 -18 -13 -21 -27
Net Cash From Continuing Investing Activities
-43 105 30 -39 46 -39 -23 -18 -13 -21 -27
Purchase of Investment Securities
-48 -35 -65 -42 -61 -50 -33 -18 -28 -21 -29
Sale and/or Maturity of Investments
5.64 140 96 2.97 106 12 10 0.21 15 0.00 2.39
Net Cash From Financing Activities
-139 -57 -64 -38 -78 -136 -14 -25 17 -29 -15
Net Cash From Continuing Financing Activities
-139 -57 -64 -38 -78 -136 -14 -25 17 -29 -15
Repayment of Debt
-1,417 -0.50 -0.50 -162 -58 -110 -0.51 -0.52 -354 -0.55 -0.55
Repurchase of Common Equity
-70 -43 -50 - - -6.85 - -10 - -15 -1.00
Payment of Dividends
-14 -13 -13 -13 -13 -13 -13 -13 -13 -13 -13
Other Financing Activities, Net
-15 -0.44 -0.51 -2.32 -0.38 -5.93 -0.76 -1.31 -16 -0.71 -0.41

Annual Balance Sheets for Pebblebrook Hotel Trust

This table presents Pebblebrook Hotel Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
2,770 3,058 2,809 2,591 6,978 6,499 6,076 6,261 6,134 5,825 5,693
Cash and Due from Banks
53 26 33 25 83 30 124 59 41 184 207
Restricted Cash
16 9.45 7.42 7.12 24 27 12 34 11 9.89 11
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
2,344 2,674 2,673 2,456 6,534 6,333 5,882 6,079 5,875 5,491 5,319
Other Assets
62 70 66 73 137 109 58 90 206 141 157
Total Liabilities & Shareholders' Equity
2,770 3,058 2,809 2,591 6,978 6,499 6,076 6,261 6,134 5,825 5,693
Total Liabilities
988 1,298 1,200 1,087 3,208 2,867 2,812 3,097 3,049 2,975 2,905
Accrued Interest Payable
2.38 2.55 2.28 2.07 2.74 4.69 4.65 4.57 4.54 6.83 12
Other Short-Term Payables
130 172 182 173 404 319 236 262 263 251 234
Long-Term Debt
794 419 242 885 2,747 2,229 2,280 2,442 2,387 2,320 2,247
Other Long-Term Liabilities
- 522 672 27 55 314 291 388 394 397 413
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,782 1,761 1,609 1,504 3,770 3,632 3,264 3,164 3,085 2,850 2,788
Total Preferred & Common Equity
1,781 1,758 1,606 1,499 3,760 3,621 3,257 3,156 2,997 2,764 2,697
Preferred Stock
0.14 0.14 0.10 0.10 0.20 0.20 0.20 0.30 0.29 0.28 0.28
Total Common Equity
1,781 1,758 1,606 1,499 3,760 3,621 3,257 3,156 2,996 2,763 2,697
Common Stock
1,865 1,869 1,777 1,686 4,067 4,071 4,171 4,269 4,184 4,080 4,073
Accumulated Other Comprehensive Income / (Loss)
-0.34 -4.75 -2.31 3.69 1.33 -25 -60 -19 36 24 17
Other Equity Adjustments
- - - - -309 -425 -854 -1,094 -1,223 -1,341 -1,393
Noncontrolling Interest
1.32 2.45 3.43 4.63 10 11 6.99 7.72 88 87 90

Quarterly Balance Sheets for Pebblebrook Hotel Trust

This table presents Pebblebrook Hotel Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025
Total Assets
6,389 6,336 6,078 6,073 5,999 5,698 5,704 5,723 5,651 5,653
Cash and Due from Banks
32 191 139 176 183 57 102 134 208 256
Restricted Cash
31 19 8.03 11 8.95 8.27 9.49 10 10 11
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
6,039 5,965 5,703 5,714 5,553 5,475 5,443 5,400 5,282 5,249
Other Assets
287 161 228 173 254 158 150 178 151 137
Total Liabilities & Shareholders' Equity
6,389 6,336 6,078 6,073 5,999 5,698 5,704 5,723 5,651 5,653
Total Liabilities
3,196 3,113 3,074 3,069 3,059 2,884 2,870 2,881 2,924 2,922
Accrued Interest Payable
4.82 10 9.36 8.09 11 10 6.64 9.61 21 10
Other Short-Term Payables
273 291 271 271 285 259 250 256 231 244
Long-Term Debt
2,518 2,419 2,388 2,389 2,367 2,207 2,207 2,208 2,247 2,248
Other Long-Term Liabilities
400 393 405 402 397 409 406 408 425 420
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,193 3,223 3,004 3,004 2,939 2,814 2,834 2,842 2,726 2,731
Total Preferred & Common Equity
3,106 3,136 2,916 2,914 2,849 2,726 2,746 2,752 2,635 2,639
Preferred Stock
0.30 0.30 0.29 0.29 0.29 0.28 0.28 0.28 0.28 0.28
Total Common Equity
3,106 3,135 2,915 2,914 2,849 2,726 2,745 2,752 2,635 2,638
Common Stock
4,272 4,275 4,144 4,096 4,098 4,076 4,079 4,071 4,062 4,063
Accumulated Other Comprehensive Income / (Loss)
24 39 30 44 46 31 29 11 11 6.87
Other Equity Adjustments
-1,191 -1,178 -1,258 -1,226 -1,295 -1,381 -1,362 -1,331 -1,438 -1,431
Noncontrolling Interest
87 88 88 90 90 88 89 90 91 92

Annual Metrics And Ratios for Pebblebrook Hotel Trust

This table displays calculated financial ratios and metrics derived from Pebblebrook Hotel Trust's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
22.66% 27.93% 5.47% -5.52% 5.84% -114.00% 4.03% 7.17% 1,436.92% -108.95% 2.79%
EBITDA Growth
43.54% 38.69% 29.28% -16.24% -31.91% 166.92% -141.56% 135.12% 208.06% 4.26% 23.17%
EBIT Growth
81.35% 36.93% 51.45% -29.13% -86.70% 826.26% -428.30% 53.02% 54.26% 8.70% 63.51%
NOPAT Growth
78.61% 39.19% 55.87% -29.38% -88.21% 902.03% -340.08% 53.02% 54.26% 8.70% 63.51%
Net Income Growth
70.27% 29.17% -22.14% 35.56% -86.65% 764.59% -439.25% 52.53% 54.40% 12.60% 100.02%
EPS Growth
121.88% 32.39% -31.91% 85.94% -105.04% 1,150.00% -615.87% 44.62% 47.22% 2.11% 58.06%
Operating Cash Flow Growth
50.10% 36.85% 8.72% -19.31% -29.92% 191.24% -151.06% 135.07% 293.90% -15.26% 16.43%
Free Cash Flow Firm Growth
-151.55% 169.55% 48.22% -165.01% -1,052.17% 118.74% -95.00% -596.17% 138.79% 232.83% -53.21%
Invested Capital Growth
29.42% -10.73% -17.53% 23.54% 172.81% -10.06% -5.40% 1.10% -2.39% -5.51% -2.62%
Revenue Q/Q Growth
5.11% 4.98% 0.52% -2.36% 6.13% -107.96% 89.19% 79.47% 1,469.69% 1.34% -2.26%
EBITDA Q/Q Growth
6.80% 7.79% 0.37% -4.48% -30.85% 39.91% -600.41% 176.51% 1.57% -1.43% -4.45%
EBIT Q/Q Growth
7.87% 8.64% -0.77% -7.80% -86.50% 329.28% -89.35% 40.25% 2.11% -3.74% -46.06%
NOPAT Q/Q Growth
7.87% 9.82% 0.10% -7.95% -87.71% 209.23% -89.35% 40.25% 2.11% -3.74% -46.06%
Net Income Q/Q Growth
7.47% 7.84% -5.82% -6.08% -89.26% 3,727.74% -96.46% 41.16% 3.36% -2.86% -99.80%
EPS Q/Q Growth
5.97% 13.25% -4.48% -7.75% -103.90% 166.32% -82.58% 35.25% 8.65% -1.09% -56.00%
Operating Cash Flow Q/Q Growth
6.58% 9.99% -3.24% -5.75% -36.40% 40.65% -197.79% 763.53% -0.78% 4.23% 14.74%
Free Cash Flow Firm Q/Q Growth
-139.07% 165.26% -43.30% -179.00% -1,334.07% 119.80% 52.46% -111.01% 163.68% -12.73% -52.44%
Invested Capital Q/Q Growth
17.05% -18.96% -6.23% 39.19% 210.75% -0.43% -2.96% 0.34% -3.02% -2.57% -0.30%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
23.81% 25.81% 31.63% 28.05% 18.04% 0.00% 0.00% 0.00% 12.99% 0.00% 0.00%
EBIT Margin
11.62% 12.44% 17.86% 13.40% 1.68% 0.00% 0.00% 0.00% -6.60% 0.00% 0.00%
Profit (Net Income) Margin
12.81% 12.93% 9.55% 13.70% 1.73% 0.00% 0.00% 0.00% -6.58% 0.00% 0.00%
Tax Burden Percent
95.77% 97.35% 100.18% 99.82% 88.48% 95.72% 99.07% 100.03% 100.33% 100.89% -0.06%
Interest Burden Percent
115.08% 106.80% 53.35% 102.41% 115.92% 100.02% 99.87% 99.94% 99.34% 94.57% 90.16%
Effective Tax Rate
4.23% 2.65% -0.18% 0.18% 11.52% 4.28% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
2.75% 3.58% 6.48% 4.53% 0.26% 0.00% 0.00% 0.00% -1.08% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
4.12% 4.43% -7.76% 4.92% 0.36% 0.00% 0.00% 0.00% -2.13% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
1.77% 1.78% -2.09% 1.91% 0.25% 0.00% 0.00% 0.00% -1.64% 0.00% 0.00%
Return on Equity (ROE)
4.52% 5.36% 4.39% 6.44% 0.51% 3.13% -11.39% -5.80% -2.72% -2.50% 0.00%
Cash Return on Invested Capital (CROIC)
-22.90% 14.92% 25.69% -16.53% -92.45% 12.46% 0.68% -3.43% 1.34% 4.65% 2.27%
Operating Return on Assets (OROA)
2.73% 3.14% 4.72% 3.63% 0.27% 0.00% 0.00% 0.00% -1.38% 0.00% 0.00%
Return on Assets (ROA)
3.01% 3.26% 2.52% 3.71% 0.28% 0.00% 0.00% 0.00% -1.37% 0.00% 0.00%
Return on Common Equity (ROCE)
4.51% 5.36% 4.38% 6.43% 0.51% 3.12% -11.36% -5.78% -2.68% -2.43% 0.00%
Return on Equity Simple (ROE_SIMPLE)
4.13% 5.40% 4.61% 6.69% 0.36% 3.20% -12.05% -5.91% -2.84% -2.69% 0.00%
Net Operating Profit after Tax (NOPAT)
64 89 139 98 12 116 -278 -130 -60 -54 -20
NOPAT Margin
11.13% 12.11% 17.89% 13.37% 1.49% 0.00% 0.00% 0.00% -4.62% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-1.38% -0.85% 14.24% -0.39% -0.10% 0.00% 5.09% 2.37% 1.05% 0.84% -0.87%
SG&A Expenses to Revenue
46.87% 46.18% 0.00% 0.00% 0.28% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
88.38% 87.56% 82.14% 86.60% 98.32% 0.00% 0.00% 0.00% 106.60% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
67 91 138 98 13 121 -397 -186 -85 -78 -28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
137 190 245 205 140 373 -155 54 168 175 215
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.36 0.93 1.14 1.53 0.49 0.96 0.75 0.93 0.58 0.69 0.60
Price to Tangible Book Value (P/TBV)
1.38 0.94 1.17 1.56 0.51 0.96 0.75 0.93 0.58 0.69 0.60
Price to Revenue (P/Rev)
4.21 2.22 2.37 3.14 2.36 0.00 0.00 0.00 1.35 0.00 0.00
Price to Earnings (P/E)
50.63 23.71 39.11 27.43 0.00 41.78 0.00 0.00 0.00 0.00 0.00
Dividend Yield
2.58% 5.47% 5.96% 4.56% 5.73% 5.73% 0.21% 0.18% 0.30% 0.25% 0.30%
Earnings Yield
1.98% 4.22% 2.56% 3.65% 0.00% 2.39% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.22 0.93 1.10 1.32 0.69 0.96 0.83 0.94 0.76 0.80 0.74
Enterprise Value to Revenue (EV/Rev)
5.56 2.97 2.74 4.31 5.78 0.00 0.00 0.00 3.23 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
23.38 11.50 8.66 15.37 32.05 15.13 0.00 96.90 24.88 23.63 17.37
Enterprise Value to EBIT (EV/EBIT)
47.89 23.86 15.35 32.17 343.29 46.71 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
50.00 24.51 15.32 32.23 387.96 48.80 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
19.81 9.88 8.85 16.30 33.01 14.29 0.00 74.57 14.97 17.50 13.61
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 5.88 3.86 0.00 0.00 7.32 118.99 0.00 56.20 16.72 32.35
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.47 0.33 0.20 0.59 0.73 0.61 0.70 0.77 0.77 0.81 0.81
Long-Term Debt to Equity
0.45 0.24 0.15 0.59 0.73 0.61 0.70 0.77 0.77 0.81 0.81
Financial Leverage
0.43 0.40 0.27 0.39 0.69 0.67 0.65 0.73 0.77 0.79 0.81
Leverage Ratio
1.50 1.65 1.74 1.73 1.81 1.82 1.82 1.92 1.98 2.02 2.04
Compound Leverage Factor
1.73 1.76 0.93 1.78 2.10 1.82 1.82 1.92 1.97 1.91 1.84
Debt to Total Capital
32.13% 24.90% 16.78% 37.06% 42.15% 38.03% 41.13% 43.56% 43.63% 44.87% 44.63%
Short-Term Debt to Total Capital
1.90% 7.04% 4.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
30.23% 17.86% 12.54% 37.06% 42.15% 38.03% 41.13% 43.56% 43.63% 44.87% 44.63%
Preferred Equity to Total Capital
0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.01% 0.01%
Noncontrolling Interests to Total Capital
0.05% 0.10% 0.18% 0.19% 0.15% 0.18% 0.13% 0.14% 1.61% 1.68% 1.80%
Common Equity to Total Capital
67.81% 74.99% 83.04% 62.74% 57.69% 61.78% 58.74% 56.30% 54.76% 53.45% 53.57%
Debt to EBITDA
6.17 3.08 1.32 4.31 19.65 5.97 -14.71 44.84 14.23 13.26 10.43
Net Debt to EBITDA
5.67 2.89 1.16 4.15 18.88 5.82 -13.83 43.14 13.92 12.16 9.42
Long-Term Debt to EBITDA
5.81 2.21 0.99 4.31 19.65 5.97 -14.71 44.84 14.23 13.26 10.43
Debt to NOPAT
13.21 6.56 2.34 9.04 237.90 19.27 -8.21 -18.71 -40.00 -42.57 -112.99
Net Debt to NOPAT
12.12 6.16 2.05 8.71 228.57 18.78 -7.72 -18.01 -39.12 -39.02 -102.05
Long-Term Debt to NOPAT
12.42 4.71 1.75 9.04 237.90 19.27 -8.21 -18.71 -40.00 -42.57 -112.99
Noncontrolling Interest Sharing Ratio
0.10% 0.11% 0.18% 0.27% 0.28% 0.29% 0.26% 0.24% 1.54% 2.96% 3.15%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-533 371 550 -357 -4,117 771 39 -191 74 247 116
Operating Cash Flow to CapEx
306.90% 221.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-19.70 9.56 12.60 -9.58 -76.34 7.11 0.37 -1.98 0.74 2.14 1.03
Operating Cash Flow to Interest Expense
5.96 5.69 5.50 5.19 2.52 3.64 -1.94 0.73 2.79 2.04 2.45
Operating Cash Flow Less CapEx to Interest Expense
4.02 3.12 11.06 5.19 2.52 3.64 -1.94 0.73 2.79 2.04 2.45
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.24 0.25 0.26 0.27 0.16 0.00 0.00 0.00 0.21 0.00 0.00
Fixed Asset Turnover
0.28 0.29 0.29 0.29 0.17 0.00 0.00 0.00 0.22 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,626 2,345 1,934 2,389 6,517 5,861 5,545 5,606 5,472 5,170 5,035
Invested Capital Turnover
0.25 0.30 0.36 0.34 0.17 0.00 0.00 0.00 0.23 0.00 0.00
Increase / (Decrease) in Invested Capital
597 -282 -411 455 4,128 -656 -316 61 -134 -302 -136
Enterprise Value (EV)
3,195 2,180 2,124 3,156 4,480 5,646 4,592 5,277 4,174 4,133 3,742
Market Capitalization
2,419 1,630 1,836 2,298 1,830 3,463 2,441 2,920 1,750 1,920 1,622
Book Value per Share
$26.29 $24.47 $22.28 $21.74 $54.46 $27.72 $24.88 $24.02 $22.79 $22.93 $22.53
Tangible Book Value per Share
$25.83 $24.05 $21.87 $21.32 $51.56 $27.72 $24.88 $24.02 $22.79 $22.93 $22.53
Total Capital
2,626 2,345 1,934 2,389 6,517 5,861 5,545 5,606 5,472 5,170 5,035
Total Debt
844 584 324 885 2,747 2,229 2,280 2,442 2,387 2,320 2,247
Total Long-Term Debt
794 419 242 885 2,747 2,229 2,280 2,442 2,387 2,320 2,247
Net Debt
775 548 284 853 2,639 2,172 2,144 2,350 2,335 2,126 2,029
Capital Expenditures (CapEx)
53 100 -242 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
-9.64 -6.05 65 -2.36 -1.84 -0.03 115 56 25 20 -20
Net Nonoperating Obligations (NNO)
844 584 324 885 2,747 2,229 2,280 2,442 2,387 2,320 2,247
Total Depreciation and Amortization (D&A)
70 98 107 107 127 252 242 241 253 253 244
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.72 $0.95 $0.65 $1.20 $0.00 $0.63 ($3.25) ($1.80) ($0.95) ($0.93) ($0.39)
Adjusted Weighted Average Basic Shares Outstanding
65.65M 71.72M 71.90M 69.59M 74.29M 130.47M 130.61M 130.80M 130.45M 121.81M 119.77M
Adjusted Diluted Earnings per Share
$0.71 $0.94 $0.64 $1.19 $0.00 $0.63 ($3.25) ($1.80) ($0.95) ($0.93) ($0.39)
Adjusted Weighted Average Diluted Shares Outstanding
66.26M 72.38M 72.37M 69.98M 74.29M 130.72M 130.61M 130.80M 130.45M 121.81M 119.77M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.63 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
71.72M 71.95M 72.12M 68.99M 130.52M 130.96M 131.32M 131.49M 125.98M 120.29M 119.81M
Normalized Net Operating Profit after Tax (NOPAT)
64 89 106 98 78 -1,419 -528 -679 -1.28 -1,012 -1,003
Normalized NOPAT Margin
11.13% 12.11% 13.62% 13.38% 10.06% 0.00% 0.00% 0.00% -0.10% 0.00% 0.00%
Pre Tax Income Margin
13.37% 13.28% 9.53% 13.72% 1.95% 0.00% 0.00% 0.00% -6.56% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.47 2.36 3.17 2.63 0.24 1.11 -3.81 -1.93 -0.85 -0.67 -0.25
NOPAT to Interest Expense
2.36 2.29 3.18 2.62 0.21 1.07 -2.67 -1.35 -0.60 -0.47 -0.18
EBIT Less CapEx to Interest Expense
0.52 -0.22 8.73 2.63 0.24 1.11 -3.81 -1.93 -0.85 -0.67 -0.25
NOPAT Less CapEx to Interest Expense
0.42 -0.28 8.74 2.62 0.21 1.07 -2.67 -1.35 -0.60 -0.47 -0.18
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
109.38% 115.78% 171.83% 123.10% 910.15% 187.85% -22.04% -24.00% -61.96% -72.13% 325,300.00%
Augmented Payout Ratio
110.24% 120.09% 175.21% 218.83% 928.88% 191.32% -22.36% -24.38% -145.19% -197.01% 430,618.75%

Quarterly Metrics And Ratios for Pebblebrook Hotel Trust

This table displays calculated financial ratios and metrics derived from Pebblebrook Hotel Trust's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5,881.81% -21.52% -27.56% -23.99% -102.03% 3.68% 5.43% 9.98% -8.98% -2.69% 2.35%
EBITDA Growth
13.11% 203.98% 14.79% -89.07% -11.40% -14.46% -12.40% 700.07% -50.76% -21.89% -7.83%
EBIT Growth
4.29% 77.82% 57.25% -309.82% -6.85% -25.07% -27.02% 133.54% -20.44% -23.63% -23.99%
NOPAT Growth
4.29% 77.82% 57.15% -252.54% -6.85% -25.07% -29.19% 208.52% -20.44% -23.63% -44.21%
Net Income Growth
6.90% 78.00% 60.37% -314.73% -5.17% -24.84% -30.19% 179.93% -18.88% -16.93% -40.18%
EPS Growth
21.95% 68.24% 100.00% -670.00% -3.13% -18.52% -33.33% 142.11% -42.42% -15.63% -62.50%
Operating Cash Flow Growth
-8.23% 19.05% -28.71% -26.59% 39.38% -0.50% 13.08% -7.29% 104.20% 9.44% 8.21%
Free Cash Flow Firm Growth
215.67% 182.96% 315.83% 1,103.64% 157.50% 192.94% 5.66% 1.46% -63.62% -93.69% -79.06%
Invested Capital Growth
-2.39% -2.46% -5.56% -5.95% -5.51% -6.90% -6.51% -4.84% -2.62% -0.92% -1.24%
Revenue Q/Q Growth
5,546.27% 6.17% -7.71% -5.00% 10.82% 4.49% -5.75% 0.05% -7.96% 10.00% -0.55%
EBITDA Q/Q Growth
-75.39% 75.40% 171.01% -90.66% 99.52% 69.35% 177.53% -14.68% -87.72% 168.65% 227.45%
EBIT Q/Q Growth
-250.79% 45.80% 303.63% -226.08% 23.21% 36.56% 218.82% -42.06% -375.76% 34.88% 173.05%
NOPAT Q/Q Growth
-209.63% 45.80% 390.70% -188.31% 23.21% 36.56% 264.59% 35.34% -185.22% 34.88% 174.27%
Net Income Q/Q Growth
-251.56% 44.70% 309.49% -222.30% 25.77% 34.37% 217.15% 40.03% -210.42% 35.44% 159.93%
EPS Q/Q Growth
-420.00% 15.63% 188.89% -337.50% 42.11% 3.03% 150.00% 50.00% -295.83% 21.28% 116.22%
Operating Cash Flow Q/Q Growth
-78.23% 89.99% 60.06% 10.90% -58.67% 35.64% 81.89% -9.07% -8.97% -27.31% 79.86%
Free Cash Flow Firm Q/Q Growth
457.06% 14.33% 201.46% -18.45% -8.39% 30.07% 8.73% -21.69% -67.15% -77.44% 260.80%
Invested Capital Q/Q Growth
-3.02% -1.46% 0.01% -1.60% -2.57% -2.90% 0.43% 0.16% -0.30% -1.21% 0.11%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
1.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
-3.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
-2.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
98.18% 100.00% 99.93% 101.48% 99.53% 100.17% 96.96% 226.50% 97.13% 91.05% 71.17%
Interest Burden Percent
99.01% 99.18% 102.10% 97.54% 96.14% 98.83% 100.66% 104.14% 97.24% 102.83% 107.93%
Effective Tax Rate
0.00% 0.00% 0.07% 0.00% 0.00% 0.00% 3.04% -126.50% 0.00% 0.00% 28.83%
Return on Invested Capital (ROIC)
-0.49% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.95% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-0.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-1.23% -0.22% 0.34% -2.34% -2.50% -2.74% -3.21% 0.27% 0.00% -0.17% -0.63%
Cash Return on Invested Capital (CROIC)
1.34% 2.40% 5.88% 5.17% 4.65% 6.02% 5.45% 4.70% 2.27% 0.44% 0.65%
Operating Return on Assets (OROA)
-0.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
-0.61% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-1.21% -0.22% 0.33% -2.28% -2.43% -2.66% -3.11% 0.27% 0.00% -0.16% -0.61%
Return on Equity Simple (ROE_SIMPLE)
0.00% -0.23% 0.36% -2.53% 0.00% -2.93% -3.41% 0.29% 0.00% -0.18% -0.67%
Net Operating Profit after Tax (NOPAT)
-29 -16 45 -40 -31 -19 32 43 -37 -24 18
NOPAT Margin
-2.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.46% 0.27% -0.04% 0.69% 0.48% 0.35% -0.01% -0.08% 0.57% 0.36% -0.06%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
103.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-41 -22 45 -57 -44 -28 33 19 -53 -34 25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
22 39 106 9.91 20 33 93 79 9.74 26 86
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.58 0.60 0.59 0.57 0.69 0.68 0.60 0.58 0.60 0.46 0.45
Price to Tangible Book Value (P/TBV)
0.58 0.60 0.59 0.57 0.69 0.68 0.60 0.58 0.60 0.46 0.45
Price to Revenue (P/Rev)
1.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.30% 0.29% 0.29% 0.30% 0.25% 0.26% 0.29% 0.30% 0.30% 0.39% 0.40%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.76 0.76 0.74 0.73 0.80 0.81 0.76 0.74 0.74 0.67 0.65
Enterprise Value to Revenue (EV/Rev)
3.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
24.88 16.74 15.51 21.97 23.63 24.11 24.61 16.62 17.37 16.02 16.23
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 434.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 446.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
14.97 14.30 15.62 17.20 17.50 17.29 15.64 15.64 13.61 11.94 11.39
Enterprise Value to Free Cash Flow (EV/FCFF)
56.20 31.29 12.26 13.76 16.72 13.01 13.51 15.41 32.35 152.80 100.70
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.77 0.79 0.80 0.81 0.81 0.78 0.78 0.78 0.81 0.82 0.82
Long-Term Debt to Equity
0.77 0.79 0.80 0.81 0.81 0.78 0.78 0.78 0.81 0.82 0.82
Financial Leverage
0.77 0.79 0.79 0.78 0.79 0.79 0.79 0.79 0.81 0.80 0.80
Leverage Ratio
1.98 2.01 2.01 2.00 2.02 2.02 2.02 2.03 2.04 2.05 2.04
Compound Leverage Factor
1.96 2.00 2.05 1.95 1.94 2.00 2.03 2.11 1.99 2.11 2.20
Debt to Total Capital
43.63% 44.29% 44.30% 44.61% 44.87% 43.96% 43.78% 43.72% 44.63% 45.19% 45.15%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
43.63% 44.29% 44.30% 44.61% 44.87% 43.96% 43.78% 43.72% 44.63% 45.19% 45.15%
Preferred Equity to Total Capital
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
Noncontrolling Interests to Total Capital
1.61% 1.64% 1.66% 1.70% 1.68% 1.74% 1.76% 1.78% 1.80% 1.83% 1.86%
Common Equity to Total Capital
54.76% 54.07% 54.04% 53.69% 53.45% 54.30% 54.46% 54.49% 53.57% 52.97% 52.99%
Debt to EBITDA
14.23 9.76 9.25 13.34 13.26 13.04 14.14 9.79 10.43 10.80 11.19
Net Debt to EBITDA
13.92 9.17 8.53 12.26 12.16 12.65 13.43 9.15 9.42 9.75 9.86
Long-Term Debt to EBITDA
14.23 9.76 9.25 13.34 13.26 13.04 14.14 9.79 10.43 10.80 11.19
Debt to NOPAT
-40.00 -469.96 266.63 -45.06 -42.57 -37.79 -32.96 -162.17 -112.99 -91.80 -74.86
Net Debt to NOPAT
-39.12 -441.12 245.84 -41.41 -39.02 -36.68 -31.30 -151.57 -102.05 -82.88 -65.96
Long-Term Debt to NOPAT
-40.00 -469.96 266.63 -45.06 -42.57 -37.79 -32.96 -162.17 -112.99 -91.80 -74.86
Noncontrolling Interest Sharing Ratio
1.54% 1.59% 2.86% 2.89% 2.96% 3.03% 3.07% 3.12% 3.15% 3.24% 3.27%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
105 120 363 296 271 353 383 300 99 22 80
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
3.60 4.39 12.28 9.54 9.80 13.34 13.72 10.75 3.27 0.82 2.94
Operating Cash Flow to Interest Expense
0.83 1.69 2.50 2.65 1.23 1.74 2.99 2.72 2.30 1.86 3.32
Operating Cash Flow Less CapEx to Interest Expense
0.83 1.69 2.50 2.65 1.23 1.74 2.99 2.72 2.30 1.86 3.32
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,472 5,392 5,393 5,306 5,170 5,020 5,042 5,050 5,035 4,974 4,979
Invested Capital Turnover
0.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
-134 -136 -318 -336 -302 -372 -351 -257 -136 -46 -62
Enterprise Value (EV)
4,174 4,093 4,004 3,899 4,133 4,080 3,842 3,748 3,742 3,335 3,259
Market Capitalization
1,750 1,763 1,711 1,633 1,920 1,851 1,657 1,594 1,622 1,214 1,186
Book Value per Share
$22.79 $23.14 $23.67 $23.64 $22.93 $22.70 $22.78 $22.84 $22.53 $21.99 $22.23
Tangible Book Value per Share
$22.79 $23.14 $23.67 $23.64 $22.93 $22.70 $22.78 $22.84 $22.53 $21.99 $22.23
Total Capital
5,472 5,392 5,393 5,306 5,170 5,020 5,042 5,050 5,035 4,974 4,979
Total Debt
2,387 2,388 2,389 2,367 2,320 2,207 2,207 2,208 2,247 2,247 2,248
Total Long-Term Debt
2,387 2,388 2,389 2,367 2,320 2,207 2,207 2,208 2,247 2,247 2,248
Net Debt
2,335 2,241 2,202 2,175 2,126 2,142 2,096 2,063 2,029 2,029 1,981
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
11 6.49 -0.95 17 11 8.06 -0.21 -1.80 13 8.12 -1.42
Net Nonoperating Obligations (NNO)
2,387 2,388 2,389 2,367 2,320 2,207 2,207 2,208 2,247 2,247 2,248
Total Depreciation and Amortization (D&A)
63 61 61 67 64 61 60 60 63 61 61
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.33) ($0.27) $0.27 ($0.57) ($0.36) ($0.32) $0.17 $0.27 ($0.51) ($0.37) $0.06
Adjusted Weighted Average Basic Shares Outstanding
130.45M 125.49M 121.70M 120.06M 121.81M 120.09M 120.09M 119.64M 119.77M 119.20M 118.17M
Adjusted Diluted Earnings per Share
($0.32) ($0.27) $0.24 ($0.57) ($0.33) ($0.32) $0.16 $0.24 ($0.47) ($0.37) $0.06
Adjusted Weighted Average Diluted Shares Outstanding
130.45M 125.49M 151.24M 120.06M 121.81M 120.09M 149.74M 149.35M 119.77M 119.20M 118.38M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
125.98M 123.11M 120.50M 120.50M 120.29M 120.50M 120.50M 119.69M 119.81M 118.69M 118.57M
Normalized Net Operating Profit after Tax (NOPAT)
724 -234 -362 -267 -265 -239 -353 -268 -273 -248 -272
Normalized NOPAT Margin
53.16% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
-2.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-1.40 -0.81 1.53 -1.84 -1.58 -1.05 1.18 0.69 -1.75 -1.27 0.92
NOPAT to Interest Expense
-0.98 -0.57 1.53 -1.29 -1.11 -0.74 1.15 1.55 -1.23 -0.89 0.65
EBIT Less CapEx to Interest Expense
-1.40 -0.81 1.53 -1.84 -1.58 -1.05 1.18 0.69 -1.75 -1.27 0.92
NOPAT Less CapEx to Interest Expense
-0.98 -0.57 1.53 -1.29 -1.11 -0.74 1.15 1.55 -1.23 -0.89 0.65
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-61.96% -784.63% 512.20% -74.84% -72.13% -66.66% -56.32% 660.60% 325,300.00% -1,120.46% -295.58%
Augmented Payout Ratio
-145.19% -2,434.49% 2,047.41% -299.68% -197.01% -137.95% -63.63% 872.99% 430,618.75% -1,650.43% -441.12%

Key Financial Trends

Pebblebrook Hotel Trust (NYSE: PEB) recently reported its Q2 2025 financial results, offering a mixed but cautiously positive picture when viewed in the context of trends over the past four years.

Notably, in Q2 2025, Pebblebrook generated a consolidated net income of $19.3 million, a significant turnaround compared to losses seen in prior quarters, including substantial net losses through much of 2023 and early 2024. This improvement marks a positive inflection point in profitability for the trust.

The company's core operating cash flow remains strong, with net cash from continuing operating activities at about $90.5 million in Q2 2025, indicating solid cash generation capability. Depreciation and amortization expenses remain high but stable around $57.6 million and $2.9 million respectively, reflecting ongoing asset usage but not a sudden increase in costs.

However, financing and investing activities show continued cash outflows, particularly in net cash from continuing financing activities at -$14.95 million and investing activities at -$26.64 million, reflective of ongoing capital deployment and debt repayments.

Financial highlights and trends from the past few years include:

  • Improved profitability in Q2 2025 with net income turning positive at $19.3 million versus prior quarters' net losses up to tens of millions
  • Strong operating cash flow with consistent generation above $50 million per quarter and recent increase to $90.5 million in Q2 2025
  • Stable depreciation expense (~$57 million quarterly) indicating consistent asset operations without unexpected write-downs
  • Gradual reduction in outstanding long-term debt interest expense from $31 million in Q3 2023 to about $27 million in Q2 2025, signaling potential debt management improvements
  • Cash and equivalents increased over time, from ~$138 million in Q1 2023 to ~$256 million in Q2 2025, providing liquidity cushion
  • Modest fluctuations in other operating expenses and insurance claims costs; these remain high but manageable relative to revenues
  • Reduction in total liabilities from high $3.2 billion in 2022-2023 to $2.92 billion by Q2 2025, improving balance sheet strength
  • Common equity remains steady near $2.6-$2.9 billion, maintaining solid equity base
  • Large and recurring 'Other Special Charges' (negative values downward of $300 million each quarter), which significantly depress reported earnings and require investor attention
  • Although improving, diluted earnings per share remain low, recording $0.06 in Q2 2025 after multiple quarters of negative EPS as low as -$0.57 in Q4 2023

Overall, Pebblebrook Hotel Trust is showing encouraging signs of financial stabilization and gradual recovery with better profitability and operating cash flow in recent quarters. However, the presence of significant non-recurring or special charges and historically weak earnings per share signal the need for investors to watch the company's execution and sustainability of this improved performance.

In summary, retail investors should view Pebblebrook’s recent results as a potential turnaround in the hospitality real estate sector with improving fundamentals but also remain mindful of ongoing risks related to earnings volatility and special charge impacts.

08/03/25 12:57 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Pebblebrook Hotel Trust's Financials

When does Pebblebrook Hotel Trust's fiscal year end?

According to the most recent income statement we have on file, Pebblebrook Hotel Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Pebblebrook Hotel Trust's net income changed over the last 10 years?

Pebblebrook Hotel Trust's net income appears to be on an upward trend, with a most recent value of $16 thousand in 2024, falling from $73.54 million in 2014. The previous period was -$74.28 million in 2023. View Pebblebrook Hotel Trust's forecast to see where analysts expect Pebblebrook Hotel Trust to go next.

How has Pebblebrook Hotel Trust's revenue changed over the last 10 years?

Over the last 10 years, Pebblebrook Hotel Trust's total revenue changed from $574.24 million in 2014 to -$112.43 million in 2024, a change of -119.6%.

How much debt does Pebblebrook Hotel Trust have?

Pebblebrook Hotel Trust's total liabilities were at $2.91 billion at the end of 2024, a 2.3% decrease from 2023, and a 194.1% increase since 2014.

How much cash does Pebblebrook Hotel Trust have?

In the past 10 years, Pebblebrook Hotel Trust's cash and equivalents has ranged from $25.41 million in 2017 to $206.65 million in 2024, and is currently $206.65 million as of their latest financial filing in 2024.

How has Pebblebrook Hotel Trust's book value per share changed over the last 10 years?

Over the last 10 years, Pebblebrook Hotel Trust's book value per share changed from 26.29 in 2014 to 22.53 in 2024, a change of -14.3%.



This page (NYSE:PEB) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners